• Innovation, Quality & Expertise: Keys to the Post-Brexit Clinical Landscape

    Clinical Research News Contributed Commentary | Brexit has, and will continue to have, a profound impact on clinical trials in the UK and throughout Europe. While no one can know precisely what that long-term impact will be, pharma companies must be ready to adjust quickly.

    Mar 13, 2019

  • FDA Commissioner Gottlieb Resigns

    Washington Post | FDA Commissioner Scott Gottlieb, who used his post to tackle difficult public health issues from youth vaping to opioid addiction resigned Tuesday, effective in about a month.

    Mar 7, 2019

  • Microsoft Builds A Bot To Match Patients To Clinical Trials

    Seattle Times | Microsoft's Clinical Trials Bot lets patients and doctors search for studies related to a disease and then answer a succession of text questions to narrow down their availability.

    Mar 6, 2019

  • Taking Down Compliance Barriers with State Prescribing Regs

    Clinical Research News | Nearly all states require physicians to access a prescription drug monitoring program (PDMP) before writing prescriptions for controlled substances to help red-flag opioid “doctor shopping” by patients. But some doctors prefer to trust their gut, or simply can’t find the time. “The level of effort required to consult a PDMP registry is very high, almost prohibitive for physicians,” says G. Cameron Deemer, president of e-prescribing software provider DrFirst.

    Mar 6, 2019

  • Rhinogram, ZappRx, HEALTHeLINK, And More: News From February 2019

    Clinical Research News | February was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Rhinogram, ZappRx, HEALTHeLINK, and more.

    Feb 27, 2019